Generali Asset Management SPA SGR Reduces Position in Regeneron Pharmaceuticals, Inc. $REGN
MarketBeat
Generali Asset Management SPA SGR decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 36.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 7,666 shares of the biopharmaceutical company's stock after selling 4,354 sha
NASDAQ:REGN